Learn more

LACHEMA NP

Overview
  • Total Patents
    58
About

LACHEMA NP has a total of 58 patent applications. Its first patent ever was published in 1967. It filed its patents most often in Czechia, Czechoslovakia and Austria. Its main competitors in its focus markets measurement, biotechnology and surface technology and coating are SHANGHAI INNOSTAR BIO TECH CO LTD, CAVIDI TECH AB and HAI KANG LIFE CORP LTD.

Patent filings per year

Chart showing LACHEMA NPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Svoboda Vlastimil 6
#2 Celechovska Olga 6
#3 Celechovska O 6
#4 Svoboda V 6
#5 Chromy Vratislav Ing Csc 4
#6 Dyr Jan Evangelista Ing Csc 3
#7 Mistr Adolf Ing Csc 3
#8 Stanek M 2
#9 Mostecky J 2
#10 Svoboda Vlastimil Dipl Ing 2

Latest patents

Publication Filing date Title
CZ162898A3 Platinum complex of oxidation number IV, process for preparing such complex, this complex as a medicament and pharmaceutical composition in which the complex is comprised
CZ162798A3 Platinum complex of oxidation number II, process for preparing such complex, the complex functioning as medicament and pharmaceutical composition in which the complex is comprised
CZ45998A3 Injectable pharmaceutical composition for photodynamic therapy and diagnostics of tumor diseases
CZ196597A3 Magnesium fertilizer based on magnesium hydroxide aqueous suspension
CZ100997A3 Process for preparing dihydroxy acetone
CZ100897A3 Process for preparing dihydroxy acetone
CZ9601813A3 Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane
CS596290A3 Process for preparing water-soluble complex diazonium resin
CS239890A3 Negative photoresist for photolithographic process
CS9000920A3 Process for preparing fibrinogen-conversion enzyme
CS276174B6 Gelling moderators at conversion of fibrinogen to fibrin by the action of proteolytic enzymes of the batroxobin type
CS276173B6 Conversion activator of fibrinogen to fibrin by the action of proteolytic enzymes of the batroxobin type
CS639089A3 Micro-carriers with fibronectin suitable for cultivation of animal cells, process for preparing and use thereof
CS563589A3 Tablets with controlled release of dilthiazemium chloride
CS549489A3 Two-component agent for the enzymatic determination of uric acid
CS338289A3 Process for preparing disodium and dipotassium salts of 1,1-cyclobutanedicarboxylic acid
CZ57989A3 Process for preparing and purifying glucose-6-phosphate-dehydrogenase
CS431188A3 Process of natural or synthetic polyisoprene cyclization
DD289651A7 PLATINUM cytostatic
CS469085A3 Two-component agent for the determination of catalytic concentration of acid phosphatases in blood serum and plasma